 |
Predictive BiosciencesPredictive Biosciences is developing proprietary biomarker and assay technology for highly accurate, patient-friendly, real-time cancer diagnostics. The company is focused on validating and demonstrating the superior clinical utility of its protein biomarkers and developing products for commercialization across multiple cancer types. Predictive Biosciences was co-founded in 2006 by Marsha A. Moses, Ph.D., Bruce R. Zetter, Ph.D. and Eugene Chiu. Recent NewsPredictive Biosciences Closes $21.75 Million in Series B FinancingPredictive Biosciences Expands Executive Leadership Team with Two Diagnostic Industry Veteran AppointmentsPredictive Biosciences Appoints Life Sciences Industry Veteran Peter Klemm, Ph.D., as Company’s First President and CEOPredictive Biosciences Appoints Martin Madaus, Millipore CEO and Chairman, to Board of DirectorsPredictive Biosciences Forms Scientific Advisory BoardPredictive Biosciences Raises $10 Million in Series A Funding |
 CEOPeter KlemmContact Info128 Spring Street400 Level, B Annex Lexington, Massachusetts 02421 Phone: 781.402.1780 Fax: 781.402.1785 Key LinksWebsiteJobs Info Highland Team Paul Maeder
 Bijan Salehizadeh, M.D.
|